INS and type 2 diabetes mellitus: A brief report on cardiovascular effects of exenatide add-on therapy in 69 metformin-treated patients with T2D showed a significant reduction in total body fat mass, trunk fat mass, and waist circumference compared with the insulin glargine therapy.